Statistics

Total Visits

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program24

Select a period of time:

Number of views in the range

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program13

Views

Views
May 20245
June 20240
July 20241
August 20243
September 20241
October 20240
November 20243
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Spain2
United Kingdom1
 

Top cities views

Views
Chicago3
Oviedo2
Gallatin2
Fort Worth1
Prineville1